PDT Partners’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-9,608
| Closed | -$429K | – | 1041 |
|
|
2021
Q3 | $429K | Sell |
9,608
-2,072
| -18% | -$92.5K | 0.03% | 510 |
|
|
2021
Q2 | $637K | Sell |
11,680
-3,064
| -21% | -$167K | 0.04% | 465 |
|
|
2021
Q1 | $1.1M | Buy |
14,744
+6,289
| +74% | +$470K | 0.08% | 355 |
|
|
2020
Q4 | $917K | Buy |
8,455
+343
| +4% | +$37.2K | 0.06% | 337 |
|
|
2020
Q3 | $717K | Buy |
8,112
+4,572
| +129% | +$404K | 0.05% | 369 |
|
|
2020
Q2 | $377K | Buy |
3,540
+10
| +0.3% | +$1.07K | 0.03% | 476 |
|
|
2020
Q1 | $209K | Sell |
3,530
-330
| -9% | -$19.5K | 0.02% | 555 |
|
|
2019
Q4 | $267K | Buy |
3,860
+2,257
| +141% | +$156K | 0.02% | 571 |
|
|
2019
Q3 | $166K | Sell |
1,603
-417
| -21% | -$43.2K | 0.01% | 418 |
|
|
2019
Q2 | $187K | Buy |
+2,020
| New | +$187K | 0.01% | 371 |
|
|
2018
Q4 | – | Sell |
-5,185
| Closed | -$618K | – | 521 |
|
|
2018
Q3 | $618K | Sell |
5,185
-637
| -11% | -$75.9K | 0.03% | 346 |
|
|
2018
Q2 | $594K | Sell |
5,822
-718
| -11% | -$73.3K | 0.02% | 383 |
|
|
2018
Q1 | $849K | Buy |
6,540
+359
| +6% | +$46.6K | 0.03% | 373 |
|
|
2017
Q4 | $601K | Buy |
6,181
+1,844
| +43% | +$179K | 0.02% | 410 |
|
|
2017
Q3 | $638K | Buy |
+4,337
| New | +$638K | 0.02% | 406 |
|